John Johnson's Net Worth

$772 Thousand

Who is John Johnson?

John Johnson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sucampo Pharmaceuticals, Inc., LILLY ELI & CO, SAVIENT PHARMACEUTICALS INC, CEMPRA, INC., HISTOGENICS CORP, Verastem, Inc., AVEO PHARMACEUTICALS INC, Xeris Biopharma Holdings, Inc., Axogen, Inc., Strongbridge Biopharma plc, DENDREON CORP, PORTOLA PHARMACEUTICALS INC, TRANZYME INC, and IMCLONE SYSTEMS INC.

SEC CIK

John Johnson's CIK is 0001410781

Past Insider Trading and Trends

2021 was John Johnson's most active year for acquiring shares with 18 total transactions. John Johnson's most active month to acquire stocks was the month of May. 2024 was John Johnson's most active year for disposing of shares, totalling 6 transactions. John Johnson's most active month to dispose stocks was the month of June. 2012 saw John Johnson paying a total of $18,960,030.16 for 2,113,207 shares, this is the most they've acquired in one year. In 2011 John Johnson cashed out on 500,000 shares for a total of $4,615,000.00, their largest year based on trade value.